Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Home > Insider Trading > A Lawrence Kenyon > Profile

A Lawrence Kenyon

Affiliations

Ceo, Pres, Cfo, Treas & Secy at Outlook Therapeutics Inc. (OTLK), 2019-10-15
Chief Financial Officer at Arno Therapeutics Inc (ARNI), 2014-02-27
President, Ceo And Cfo at Tamir Biotechnology Inc. (ACEL), 2012-07-25
Other at Par Pharmaceutical Companies Inc. (PRX), 2010-08-04

Insider Trading: Purchases See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Outlook Therapeutics Inc.	OTLK	$0.90	25,000	Officer, Director	82,213	2019-02-07	Filing

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Outlook Therapeutics Inc.	OTLK	$1.70	1,350	Officer, Director	8,926	2019-09-18	Filing
Outlook Therapeutics Inc.	OTLK	$1.70	1,350	Officer, Director	80,863	2019-09-18	Filing
Oncobiologics Inc.	ONS	$0.87	10,100	Officer, Director	57,213	2018-09-18	Filing
Oncobiologics Inc.	ONS	$1.13	26,165	Officer	67,313	2017-12-22	Filing
Par Pharmaceutical Companies Inc.	PRX	$25.27	200	Officer	20,649	2010-03-03	Filing